Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGS 16617

Known as: CGS-16617 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryA new, orally active angiotensin converting enzyme (ACE) inhibitor, CGS 16617, has been evaluated in normotensive subjects… Expand
2004
2004
The intrasubject and intersubject variabilities for CGS 16617, an angiotensin converting enzyme inhibitor, were evaluated in an… Expand
Highly Cited
1991
Highly Cited
1991
The effects of six angiotensin converting enzyme inhibitors (captopril, CGS-16617, cilazapril, enalapril, utibapril, and… Expand
  • table 1
  • table 2
  • table 4
  • table 5
1990
1990
The effects of angiotensin-converting enzyme inhibitors on cardiovascular mass and function were measured in three groups of 22… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
1989
1989
The disposition and metabolism of CGS 16617 (3-[(5-amino-1-carboxy-1S-pentyl)amino],2,3,4,5-tetrahydro-2-oxo-3S-1H-1… Expand
1988
1988
Pentopril (CGS 13945) was administered in 125‐mg capsules to eight healthy men on two occasions according to a randomized… Expand
1988
1988
The present study was designed to examine the effects of two new angiotensin-converting enzyme (ACE) inhibitors, CGS 14831 and… Expand
1988
1988
  • N. Levens
  • Archives internationales de pharmacodynamie et de…
  • 1988
  • Corpus ID: 30424246
Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617 were evaluated in anesthetized dogs. Intravenous… Expand
1987
1987
The effect of a specific inhibitor of thromboxane (Tx) A2 synthesis, CGS-13080, a new angiotensin converting enzyme inhibitor… Expand
1987
1987
Abstract A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-12970, a new angiotensin-converting enzyme (ACE) inhibitor… Expand
  • figure 1